SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-368527
Filing Date
2015-11-05
Accepted
2015-11-05 17:26:34
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d78816d10q.htm 10-Q 597896
2 EX-10.1 d78816dex101.htm EX-10.1 141312
3 EX-31.1 d78816dex311.htm EX-31.1 6449
4 EX-31.2 d78816dex312.htm EX-31.2 6456
5 EX-32.1 d78816dex321.htm EX-32.1 3086
6 EX-32.2 d78816dex322.htm EX-32.2 3100
  Complete submission text file 0001193125-15-368527.txt   3853983

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cbio-20150930.xml EX-101.INS 539559
8 XBRL TAXONOMY EXTENSION SCHEMA cbio-20150930.xsd EX-101.SCH 41384
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20150930_cal.xml EX-101.CAL 54323
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20150930_def.xml EX-101.DEF 284638
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20150930_lab.xml EX-101.LAB 390174
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20150930_pre.xml EX-101.PRE 331538
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 151201784
SIC: 2834 Pharmaceutical Preparations